XML 45 R34.htm IDEA: XBRL DOCUMENT v3.23.2
Revenue Recognition - Schedule of Drug Revenue Recognition (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Disaggregation Of Revenue [Line Items]        
Drug discovery services revenue from contracts with customers $ 5,837 $ 8,458 $ 38,406 $ 24,040
Drug discovery services revenue from contracts with customers        
Disaggregation Of Revenue [Line Items]        
Drug discovery services revenue from contracts with customers 5,232 8,019 37,035 23,259
Drug discovery contribution        
Disaggregation Of Revenue [Line Items]        
Drug discovery services revenue from contracts with customers $ 605 $ 439 $ 1,371 $ 781